Journal article icon

Journal article

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.

Abstract:

BACKGROUND: Erythropoietin (Epo) has neuroprotective and neurotrophic effects in animal models and affects cognitive and associated neural responses in humans. These effects have highlighted Epo as a candidate for treatment of psychiatric disease including schizophrenia and depression. The current study aimed to explore the effects of Epo on neural and behavioral measures of emotional processing relevant for depression and the effects of conventional antidepressant medication. METHODS: In th...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Miskowiak, K More by this author
O'Sullivan, U More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Journal:
Biological psychiatry
Volume:
62
Issue:
11
Pages:
1244-1250
Publication date:
2007-12-05
DOI:
EISSN:
1873-2402
ISSN:
0006-3223
URN:
uuid:222bc2f1-a901-4123-abd4-caaccf74cbaa
Source identifiers:
139397
Local pid:
pubs:139397

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP